CHU de Nantes; Cancéro-dermatologie

Nantes 44093

0 studies enrolling now · 2 studies all time

What they study most

Advanced BRAFV600 Wild-type Melanoma, Lymphoma, Large B-Cell, Diffuse

Studies at this site

• A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax in Combination With Polatuzumab Vedotin Plus Rituximab (R) and Cyclophosphamide, Doxorubicin, Prednisone (CHP) in Participants With Untreated BCL-2 Immunohistochemistry (IHC)-Positive Diffuse Large B-Cell Lymphoma (DLBCL) — Stopped early
• A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma — Stopped early